0001104659-24-043291.txt : 20240403
0001104659-24-043291.hdr.sgml : 20240403
20240403215550
ACCESSION NUMBER: 0001104659-24-043291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DELUCCIA ROBERT J
CENTRAL INDEX KEY: 0001127423
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40536
FILM NUMBER: 24821478
MAIL ADDRESS:
STREET 1: 40 WASHINGTON STREET
STREET 2: SUITE 220
CITY: WELLESLEY HILLS
STATE: MA
ZIP: 02481
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acurx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001736243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 259 LIBERTY AVENUE
CITY: STATEN ISLAND
STATE: NY
ZIP: 10305
BUSINESS PHONE: 917-533-1469
MAIL ADDRESS:
STREET 1: 259 LIBERTY AVENUE
CITY: STATEN ISLAND
STATE: NY
ZIP: 10305
FORMER COMPANY:
FORMER CONFORMED NAME: Acurx Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20180402
4
1
tm2411025-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-23
0
0001736243
Acurx Pharmaceuticals, Inc.
ACXP
0001127423
DELUCCIA ROBERT J
C/O ACURX PHARMACEUTICALS, INC.,
259 LIBERTY AVENUE
STATEN ISLAND
NY
10305
1
0
1
0
0
Stock Option
3.15
2024-02-23
4
A
0
250000
0
A
2034-02-22
Common Stock
250000
250000
D
On February 23, 2024 (the "Grant Date"), the Reporting Person was granted stock options to purchase 250,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.
/s/ Kostantinos Skordalos, Power of Attorney For: Robert J. DeLuccia
2024-04-03